EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via enhanced CtBP1 association
Year: 2018
Type: article
Abstract: The transcriptional regulator EVI1 has an essential role in early hematopoiesis and development. However, aberrantly high expression of EVI1 has potent oncogenic properties and confers poor prognosis and chemo-resistance in leukemia and solid tumors. To investigate to what extent EVI1 function might be regulated by post-translational modifications we carried out mass spectrometry- and antibody-based analyses and uncovered an ATM-mediated double phosphorylation of EVI1 at the carboxy-terminal S858/S860 SQS motif. In the presence of genotoxic stress EVI1-WT (SQS), but not site mutated EVI1-AQA was able to maintain transcriptional patterns and transformation potency, while under standard conditions carboxy-terminal mutation had no effect. Maintenance of hematopoietic progenitor cell clonogenic potential was profoundly impaired with EVI1-AQA compared with EVI1-WT, in particular in the presence of genotoxic stress. Exploring mechanistic events underlying these observations, we showed that after genotoxic stress EVI1-WT, but not EVI1-AQA increased its level of association with its functionally essential interaction partner CtBP1, implying a role for ATM in regulating EVI1 protein interactions via phosphorylation. This aspect of EVI1 regulation is therapeutically relevant, as chemotherapy-induced genotoxicity might detrimentally sustain EVI1 function via stress response mediated phosphorylation, and ATM-inhibition might be of specific targeted benefit in EVI1-overexpressing malignancies.
Source: Nucleic Acids Research
DOI: 10.1093/nar/gky536
Authors: Roberto Paredes, Marion Schneider, Adam Stevens, Daniel J White, Andrew J K Williamson, Joanne Muter, Stella Pearson, James R Kelly, Kathleen Connors, Daniel H Wiseman, John A Chadwick, Harald Löffler, Hsiang Ying Teng, Simon Lovell, Richard Unwin, Henri J van de Vrugt, Helen Smith, Olga Kustikova, Axel Schambach, Tim C P Somervaille, Andrew Pierce, Anthony D Whetton, Stefan Meyer
Institutions: Manchester Academic Health Science Centre, University of Manchester, Cancer Research UK Manchester Institute, German Cancer Research Center, Heidelberg University, Amsterdam UMC Location Vrije Universiteit Amsterdam, Medizinische Hochschule Hannover, The Christie Hospital, The Christie NHS Foundation Trust, Royal Manchester Children's Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,063
Awards: G148601890, G1626027501, G1842356953, G1966464522, G1969094940, G2121573167, G2797483627, G2872428600, G2948622370, G3548330562, G4037624188, Manchester Molecular Pathology Innovation Centre (MMPathIC): bridging the gap between biomarker discovery and health and wealth, Manchester Academic Health Science Centre Technology Hub: Clinical Proteomics Centre for Stratified Medicine, G6014790911, G625651651, G6995585580, G8248070087
OpenAlex ID: W2805409869
